Abstract
Objectives
To evaluate the CT features of ruptured GISTs and factors that might be predictive of rupture through comparison with CTs taken prior to rupture and CTs of non-ruptured GIST.
Methods
Forty-nine patients with ruptured GIST and forty-nine patients with non-ruptured GIST matched by age, gender and location were included. Clinical data including pharmacotherapy were reviewed. The imaging features were analyzed. Prior CT obtained before rupture were evaluated.
Results
The most common location of ruptured GIST was small bowel with mean size of 12.1 cm. Ruptured GIST commonly showed wall defects, >40 % eccentric necrosis, lobulated shaped, air density in mass, pneumoperitoneum, peritonitis, hemoperitoneum and ascites (p < 0.001–0.030). Twenty-seven of 30 patients with follow up imaging received targeted therapy. During follow-up, thickness of the tumour wall decreased. Increase in size and progression of necrosis were common during targeted therapy (p = 0.017).
Newly developed ascites, peritonitis and hemoperitoneum was more common (p < 0.001–0.036).
Conclusion
Ruptured GISTs commonly demonstrate large size, >40 % eccentric necrosis, wall defects and lobulated shape. The progression of necrosis with increase in size and decreased wall thickness during targeted therapy may increase the risk of rupture. Rupture should be considered when newly developed peritonitis, hemoperitoneum, or ascites are noted during the follow-up.
Key points
• Ruptured GISTs demonstrate large size, eccentric necrosis, wall defects, and lobulated shape.
• Rupture should be considered when peritonitis or hemoperitoneum/adjacent hematoma newly appears.
• Progression of necrosis with increase in size increases the risk of rupture.
Similar content being viewed by others
References
Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577–580
Yang J, Yu J, Ma Z, Kang W, Tian S, Ye X (2015) Clinical pathological features and prognosis analysis of gastrointestinal stromal tumor: a series of 558 cases. Zhonghua Wai Ke Za Zhi 53:274–279
Demetri GD, von Mehren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–480
Hohenberger P, Ronellenfitsch U, Oladeji O et al (2010) Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg 97:1854–1859
Baheti AD, Shinagare AB, O'Neill AC et al (2015) MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience. Br J Radiol 88:20150085
Chok AY, Goh BK, Koh YX et al (2015) Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients. Ann Surg Oncol 22:3597–3605
Cegarra-Navarro MF, de la Calle MA, Girela-Baena E, Garcia-Santos JM, Lloret-Estan F, de Andres EP (2005) Ruptured gastrointestinal stromal tumors: radiologic findings in six cases. Abdom Imaging 30:535–542
Pinaikul S, Woodtichartpreecha P, Kanngurn S, Leelakiatpaiboon S (2014) 1189 Gastrointestinal stromal tumor (GIST): computed tomographic features and correlation of CT findings with histologic grade. J Med Assoc Thai 97:1189–1198
Arolfo S, Teggia PM, Nano M (2011) Gastrointestinal stromal tumors: thirty years experience of an institution. World J Gastroenterol 17:1836–1839
Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S (2002) Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 33:669–676
Zhou C, Duan X, Zhang X, Hu H, Wang D, Shen J (2015) Predictive features of CT for risk stratifications in patients with primary gastrointestinal stromal tumour. Eur Radiol 1–8
Tirumani SH, Shinagare AB, O’Neill AC, Nishino M, Rosenthal MH, Ramaiya NH (2016) Accuracy and feasibility of estimated tumour volumetry in primary gastric gastrointestinal stromal tumours: validation using semiautomated technique in 127 patients. Eur Radiol 26:286–295
Rezai P, Pisaneschi MJ, Feng C, Yaghmai V (2013) A radiologist's guide to treatment response criteria in oncologic imaging: Functional, molecular, and disease-specific imaging biomarkers. Am J Roentgenol 201:246–256
Yang TH, Hwang JI, Yang MS et al (2007) Gastrointestinal stromal tumors: computed tomographic features and prediction of malignant risk from computed tomographic imaging. J Chin Med Assoc 70:367–373
Sandrasegaran K, Rajesh A, Rushing DA, Rydberg J, Akisik FM, Henley JD (2005) Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 15:1407–1414
Lee NK, Kim S, Kim GH et al (2010) Hypervascular subepithelial gastrointestinal masses: CT-pathologic correlation. Radiographics 30:1915–1934
Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G (2002) Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol 33:466–477
Komatsu Y, Ohki E, Ueno N et al (2015) Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor. Jpn J Clin Oncol. doi:10.1093/jjco/hyv126
Kim R, Emi M, Arihiro K, Tanabe K, Uchida Y, Toge T (2005) Chemosensitization by STI571 targeting the platelet‐derived growth factor/platelet‐derived growth factor receptor‐signaling pathway in the tumor progression and angiogenesis of gastric carcinoma. Cancer 103:1800–1809
El-Kenawi AE, El-Remessy AB (2013) Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. Br J Pharmacol 170:712–729
Kamba T, McDonald D (2007) Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 96:1788–1795
Kim KW, Shinagare AB, Krajewski KM et al (2015) Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management. Korean J Radiol 16:304–313
Misawa S, Takeda M, Sakamoto H, Kirii Y, Ota H, Takagi H (2014) Spontaneous rupture of a giant gastrointestinal stromal tumor of the jejunum: a case report and literature review. World J Surg Oncol 12:153
Hamrick-Turner JE, Chiechi MV, Abbitt PL, Ros PR (1992) Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: diagnosis with CT. Radiographics 12:1051–1068
(2014) Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25 Suppl 3:iii21–26
Acknowledgments
The scientific guarantor of this publication is Hyun Jin Kim. The authors of this manuscript declare norelationships with any companies, whose products or services may be related to the subject matter ofthe article. The authors state that this work has not received any funding. No complex statisticalmethods were necessary for this paper. Institutional Review Board approval was obtained. Writteninformed consent was waived by the Institutional Review Board. Methodology: retrospective,diagnostic or prognostic study, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, J.S., Kim, H.J., Park, S.H. et al. Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours. Eur Radiol 27, 2583–2590 (2017). https://doi.org/10.1007/s00330-016-4515-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-016-4515-z